World

S Korea confirms additional bird flu case, total now at 80

Jan 30, 2021

Seoul (South Korea), January 30: South Korea's agricultural ministry said Friday it has confirmed another case of highly pathogenic bird flu at an egg farm, with the total confirmed caseload reaching 80.
The latest case of the malign H5N8 strain of avian influenza was reported from Anseong, 77 kilometers south of Seoul, according to the Ministry of Agriculture, Food and Rural Affairs. The farm was raising 790,000 chickens.
Following the case, the government issued a seven-day standstill order on all poultry farms in the city.
The number of cases from wild birds also piled up to reach 117.
Authorities have so far destroyed 23.5 million poultry to prevent the spread of the disease, which led to a sharp increase in the consumer price of related goods.
The average price of fresh eggs shot up 37 percent on-year over the past week, with those of chicken and duck meat also rising 15.7 percent and 34.1 percent, respectively.
South Korea revised its anti-animal disease law in 2018 to cull all poultry within a 3-kilometer radius of infected farms. Previously, farms were only advised to follow the order.
The revision came after the country reported a whopping 340 cases of the H5N8 strain of avian influenza traced to poultry farms between October 2016 and January 2017.
Source: Yonhap

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025